SI-BONE Inc
NASDAQ:SIBN
SI-BONE Inc
Revenue
SI-BONE Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
SI-BONE Inc
NASDAQ:SIBN
|
Revenue
$138.9m
|
CAGR 3-Years
24%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
SI-BONE Inc
Revenue Breakdown
Breakdown by Geography
SI-BONE Inc
Total Revenue:
138.9m
USD
|
United States:
130.6m
USD
|
International:
8.3m
USD
|
Breakdown by Segments
SI-BONE Inc
See Also
What is SI-BONE Inc's Revenue?
Revenue
138.9m
USD
Based on the financial report for Dec 31, 2023, SI-BONE Inc's Revenue amounts to 138.9m USD.
What is SI-BONE Inc's Revenue growth rate?
Revenue CAGR 5Y
20%
Over the last year, the Revenue growth was 31%. The average annual Revenue growth rates for SI-BONE Inc have been 24% over the past three years , 20% over the past five years .